MTA1 Overexpression Correlates Significantly with Tumor Grade and Angiogenesis in Human Breast Cancers

Overview

Journal Cancer Sci

Specialty Oncology

Date 2006 Apr 25

PMID 16630134

Citations 43

Authors

Ki-Seok Jang

Seung Sam Paik

Heekyoung Chung

Young-Ha Oh

Gu Kong

Affiliations

Soon will be listed here.

Abstract

Metastasis associated antigen 1 (MTA1) is a recently identified candidate metastasis-associated gene that plays an important role in tumorigenesis and tumor aggressiveness, especially tumor invasiveness and metastasis. We analyzed the relationship between MTA1 expression and variable clinicopathological features and characterized its role in tumor angiogenesis in human breast cancers. Two hundred and sixty-three breast cancer cases that successfully underwent surgery at Hanyang University Hospital (Seoul, Korea) between January 1989 and December 1997 were enrolled. MTA1 expression was observed by immunohistochemical staining and correlated with intratumoral microvessel density (MVD) and other clinicopathological parameters. MTA1 overexpression correlated significantly with higher tumor grade (grades 1 and 2 vs grade 3, P = 0.009). However, MTA1 expression did not correlate with tumor stage, status of estrogen and progesterone receptors, or axillary lymph node metastasis. Interestingly, MTA1 expression was found to correlate significantly with tumor MVD (P = 0.002). Survival analysis did not show a significant difference between MTA1 overexpression and poorer survival. In conclusion, MTA1 overexpression was found to be closely associated with higher tumor grade and increased tumor angiogenesis. These findings suggest MTA1 as a predictor of aggressive phenotype and a possible target molecule for anti-angiogenic drugs in breast cancer treatment.

Citing Articles

MTA1, a Novel ATP Synthase Complex Modulator, Enhances Colon Cancer Liver Metastasis by Driving Mitochondrial Metabolism Reprogramming.

Wang T, Sun F, Li C, Nan P, Song Y, Wan X Adv Sci (Weinh). 2023; 10(25):e2300756.

PMID: 37442756 PMC: 10477900. DOI: 10.1002/advs.202300756.

MTA1, a metastasis‑associated protein, in endothelial cells is an essential molecule for angiogenesis.

Ishikawa M, Osaki M, Uno N, Ohira T, Kugoh H, Okada F Mol Med Rep. 2021; 25(1).

PMID: 34779499 PMC: 8600423. DOI: 10.3892/mmr.2021.12527.

In-depth proteomics analysis of sentinel lymph nodes from individuals with endometrial cancer.

Aboulouard S, Wisztorski M, Duhamel M, Saudemont P, Cardon T, Narducci F Cell Rep Med. 2021; 2(6):100318.

PMID: 34195683 PMC: 8233695. DOI: 10.1016/j.xcrm.2021.100318.

Expression and Prognostic Significance of Metastasis-Associated Protein 1 in Gastrointestinal Cancer.

Li P, Cao W, Ding R, Cheng M, Xu X, Chen S Front Oncol. 2021; 10:542330.

PMID: 33409150 PMC: 7780747. DOI: 10.3389/fonc.2020.542330.

Metastasis-associated protein 1 (MTA1) is transferred by exosomes and contributes to the regulation of hypoxia and estrogen signaling in breast cancer cells.

Hannafon B, Gin A, Xu Y, Bruns M, Calloway C, Ding W Cell Commun Signal. 2019; 17(1):13.

PMID: 30782165 PMC: 6379974. DOI: 10.1186/s12964-019-0325-7.

References

Toh Y, Pencil S, Nicolson G . A novel candidate metastasis-associated gene, mta1, differentially expressed in highly metastatic mammary adenocarcinoma cell lines. cDNA cloning, expression, and protein analyses. J Biol Chem. 1994; 269(37):22958-63. View

Kim K, Li B, Winer J, Armanini M, Gillett N, PHILLIPS H . Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature. 1993; 362(6423):841-4. DOI: 10.1038/362841a0. View

Bagheri-Yarmand R, Talukder A, Wang R, Vadlamudi R, Kumar R . Metastasis-associated protein 1 deregulation causes inappropriate mammary gland development and tumorigenesis. Development. 2004; 131(14):3469-79. DOI: 10.1242/dev.01213. View

WEISS L, Orr F, Honn K . Interactions of cancer cells with the microvasculature during metastasis. FASEB J. 1988; 2(1):12-21. DOI: 10.1096/fasebj.2.1.3275560. View

Hofer M, Kuefer R, Varambally S, Li H, Ma J, Shapiro G . The role of metastasis-associated protein 1 in prostate cancer progression. Cancer Res. 2004; 64(3):825-9. DOI: 10.1158/0008-5472.can-03-2755. View

Toh Y, Kuninaka S, Endo K, Oshiro T, Ikeda Y, Nakashima H . Molecular analysis of a candidate metastasis-associated gene, MTA1: possible interaction with histone deacetylase 1. J Exp Clin Cancer Res. 2000; 19(1):105-11. View

Sasaki H, Moriyama S, Nakashima Y, Kobayashi Y, Yukiue H, Kaji M . Expression of the MTA1 mRNA in advanced lung cancer. Lung Cancer. 2002; 35(2):149-54. DOI: 10.1016/s0169-5002(01)00329-4. View

Toh Y, Oki E, Oda S, Tokunaga E, Ohno S, Maehara Y . Overexpression of the MTA1 gene in gastrointestinal carcinomas: correlation with invasion and metastasis. Int J Cancer. 1997; 74(4):459-63. DOI: 10.1002/(sici)1097-0215(19970822)74:4<459::aid-ijc18>3.0.co;2-4. View

Sasaki H, Yukiue H, Kobayashi Y, Nakashima Y, Kaji M, Fukai I . Expression of the MTA1 mRNA in thymoma patients. Cancer Lett. 2001; 174(2):159-63. DOI: 10.1016/s0304-3835(01)00704-2. View

10.

Hansen S, Grabau D, Rose C, Bak M, Sorensen F . Angiogenesis in breast cancer: a comparative study of the observer variability of methods for determining microvessel density. Lab Invest. 1999; 78(12):1563-73. View

11.

Qian D, Wang X, Kachhap S, Kato Y, Wei Y, Zhang L . The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584. Cancer Res. 2004; 64(18):6626-34. DOI: 10.1158/0008-5472.CAN-04-0540. View

12.

WEISS L, Orr F, Honn K . Interactions between cancer cells and the microvasculature: a rate-regulator for metastasis. Clin Exp Metastasis. 1989; 7(2):127-67. DOI: 10.1007/BF01787020. View

13.

Weidner N, Semple J, Welch W, Folkman J . Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. N Engl J Med. 1991; 324(1):1-8. DOI: 10.1056/NEJM199101033240101. View

14.

Nawa A, Nishimori K, Lin P, Maki Y, Moue K, Sawada H . Tumor metastasis-associated human MTA1 gene: its deduced protein sequence, localization, and association with breast cancer cell proliferation using antisense phosphorothioate oligonucleotides. J Cell Biochem. 2000; 79(2):202-12. View

15.

Gasparini G . Biological and clinical role of angiogenesis in breast cancer. Breast Cancer Res Treat. 1995; 36(2):103-7. DOI: 10.1007/BF00666032. View

16.

Moon W, Chang K, Tarnawski A . Overexpression of metastatic tumor antigen 1 in hepatocellular carcinoma: Relationship to vascular invasion and estrogen receptor-alpha. Hum Pathol. 2004; 35(4):424-9. DOI: 10.1016/j.humpath.2003.11.007. View

17.

Iguchi H, Imura G, Toh Y, Ogata Y . Expression of MTA1, a metastasis-associated gene with histone deacetylase activity in pancreatic cancer. Int J Oncol. 2000; 16(6):1211-4. DOI: 10.3892/ijo.16.6.1211. View

18.

Xue Y, Wong J, Moreno G, Young M, Cote J, Wang W . NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities. Mol Cell. 1999; 2(6):851-61. DOI: 10.1016/s1097-2765(00)80299-3. View

19.

Merkel D, Osborne C . Prognostic factors in breast cancer. Hematol Oncol Clin North Am. 1989; 3(4):641-52. View

20.

Arora R, Joshi K, Nijhawan R, Radotra B, Sharma S . Angiogenesis as an independent prognostic indicator in node-negative breast cancer. Anal Quant Cytol Histol. 2002; 24(4):228-33. View